TrialThe Journal of clinical investigation2019

DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial.

Nadine G Rouphael et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.